文献速递心脑血管急症重症综合管理与镇静镇痛

院外心脏骤停后良好结局预测:韩国前瞻性多中心观察研究(KORHN-PRO登记)

Good outcome prediction after out-of-hospital cardiac arrest: A prospective multicenter observational study in Korea (the KORHN-PRO registry).
PubMed 文献 · Resuscitation · 2024-04-04
一句话结论院外心脏骤停后联合临床检查、生物标志物、电生理和脑影像可预测6个月良好神经结局,联合两项预测因子可进一步提高特异度。

该研究为韩国低温网络前瞻性登记(KORHN-PRO 1.0)的回顾性分析,纳入1327例成人院外心脏骤停患者,评估临床检查、生物标志物、电生理和脑影像单独或联合预测6个月良好神经结局的能力。结果显示,入院时GCS-M>3特异度最高(96.7%,95%CI 95.3-97.8),脑DWI正常敏感度最高(96.3%,95%CI 92.9-98.4);两项预测因子联合后敏感度趋于下降(2.7%-81.1%),特异度趋于升高(81.3%-100%)。对2021年ERC/ESICM预后策略算法进行探索性变异后,该算法预测良好结局的特异度为83.2%、敏感度为83.5%。作者认为,采用良好结局预测算法可减少不确定患者数量并降低预后判断的不确定性。

要点

  • 入院时GCS-M>3预测6个月良好神经结局的特异度最高,为96.7%(95%CI 95.3-97.8)。
  • 脑DWI无缺氧性损伤预测良好结局的敏感度最高,为96.3%(95%CI 92.9-98.4)。
  • 两项良好结局预测因子联合后,敏感度趋于下降(2.7%-81.1%),特异度趋于升高(81.3%-100%)。
  • 对2021年ERC/ESICM预后策略算法进行探索性变异后,预测良好结局的特异度为83.2%、敏感度为83.5%。

适用人群与场景

  • 成人院外心脏骤停(OHCA)患者(≥18岁),来自韩国低温网络前瞻性登记KORHN-PRO 1.0。

诊断标准与关键阈值

  • 良好结局预测因子定义:入院时瞳孔对光反射(PLR)和角膜反射(CR)均存在;入院时GCS运动评分(GCS-M)>3;24-72小时神经元特异性烯醇化酶(NSE)<17 µg/L;正中神经体感诱发电位(SSEP)N20/P25波幅>4 µV;脑电图连续背景无放电;脑CT和弥散加权成像(DWI)无缺氧性损伤。

研究设计与关键结果

  • 研究类型:韩国低温网络前瞻性登记(KORHN-PRO 1.0)的回顾性分析;最终分析纳入1327例成人OHCA患者,中位年龄59岁,其中412例在6个月时神经结局良好。
  • 入院时GCS-M>3预测良好结局的特异度最高,为96.7%(95%CI 95.3-97.8);脑DWI正常预测良好结局的敏感度最高,为96.3%(95%CI 92.9-98.4)。
  • 两项良好结局预测因子联合后,敏感度趋于下降(范围2.7%-81.1%),特异度趋于升高(范围81.3%-100%)。
  • 对2021年欧洲复苏委员会(ERC)和欧洲重症医学会(ESICM)预后策略算法进行探索性变异后,该算法预测良好结局的特异度为83.2%、敏感度为83.5%。

证据类型、等级与局限

  • 证据类型:基于前瞻性多中心登记(KORHN-PRO 1.0)的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,采用良好结局预测算法可减少不确定患者数量并降低预后判断的不确定性。
  • 联合两项良好结局预测因子可提高特异度,但敏感度趋于下降(范围2.7%-81.1%)。

指南或共识出处

  • 2021年欧洲复苏委员会(ERC)和欧洲重症医学会(ESICM)预后策略算法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To assess the ability of clinical examination, biomarkers, electrophysiology and brain imaging, individually or in combination to predict good neurological outcomes at 6 months after CA.

METHODS: This was a retrospective analysis of the Korean Hypothermia Network Prospective Registry 1.0, which included adult out-of-hospital cardiac arrest (OHCA) patients (≥18 years). Good outcome predictors were defined as both pupillary light reflex (PLR) and corneal reflex (CR) at admission, Glasgow Coma Scale Motor score (GCS-M) >3 at admission, neuron-specific enolase (NSE) <17 µg/L at 24-72 h, a median nerve somatosensory evoked potential (SSEP) N20/P25 amplitude >4 µV, continuous background without discharges on electroencephalogram (EEG), and absence of anoxic injury on brain CT and diffusion-weighted imaging (DWI).

RESULTS: A total of 1327 subjects were included in the final analysis, and their median age was 59 years; among them, 412 subjects had a good neurological outcome at 6 months. GCS-M >3 at admission had the highest specificity of 96.7% (95% CI 95.3-97.8), and normal brain DWI had the highest sensitivity of 96.3% (95% CI 92.9-98.4). When the two predictors were combined, the sensitivities tended to decrease (ranging from 2.7-81.1%), and the specificities tended to increase, ranging from81.3-100%. Through the explorative variation of the 2021 European Resuscitation Council (ERC) and the European Society of Intensive Care Medicine (ESICM) prognostication strategy algorithms, good outcomes were predicted, with a specificity of 83.2% and a sensitivity of 83.5% in patients by the algorithm.

CONCLUSIONS: Clinical examination, biomarker, electrophysiology, and brain imaging predicted good outcomes at 6 months after CA. When the two predictors were combined, the specificity further improved. With the 2021 ERC/ESICM guidelines, the number of indeterminate patients and the uncertainty of prognostication can be reduced by using a good outcome prediction algorithm.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Bang HJ, Youn CS, Sandroni C, et al. Good outcome prediction after out-of-hospital cardiac arrest: A prospective multicenter observational study in Korea (the KORHN-PRO registry). Resuscitation. 2024. PMID: 38582440. doi:10.1016/j.resuscitation.2024.110207

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。